Nicole McMullen, PharmD, BCOP

Articles by Nicole McMullen, PharmD, BCOP

Image Credit: David A. Litman | stock.adobe.com

Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer

ByNicole McMullen, PharmD, BCOP,Cassandra Perkey, PharmD, BCOP,Manale Maksour, PharmD, BCPS,Bradley Winegar, PharmD,Cherise Steib, PharmD,Robert Carr, PharmD, BCOP,Melody Chang, MBA, RPh, BCOP

October 15th 2025

AI in health care -- Image credit: Toowongsa | stock.adobe.com

Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial Intelligence

ByManale Maksour, PharmD, BCPS,Cassandra Perkey, PharmD, BCOP,Brooke Peters, PharmD, BCOP,Bradley Winegar, PharmD,Nicole McMullen, PharmD, BCOP,Melody Chang, MBA, RPh, BCOP

October 16th 2024

Peer Reviewed

Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.

Latest Updated Articles

Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
October 15th 2025

Nicole McMullen, PharmD, BCOP

Articles by Nicole McMullen, PharmD, BCOP

Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer

Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial Intelligence

Latest Updated Articles

Trending on Pharmacy Times

What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results

FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults

First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma

Darovasertib Plus Crizotinib Shows Striking Efficacy in HLA-A2–Negative Metastatic Uveal Melanoma, OptimUM-02 Results Show

Early IVIG Use Associated With Reduced Infections and Improved Survival in Patients Receiving Talquetamab for Multiple Myeloma